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Mechanisms of protease-activated receptor2-evoked
hyperexcitability of nociceptive neurons innervating
the mouse colon
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Agonists of protease-activated receptor 2 (PAR2) evoke hyperexcitability of dorsal root ganglia
(DRG) neurons by unknown mechanisms. We examined the cellular mechanisms underlying
PAR2-evoked hyperexcitability of mouse colonic DRG neurons to determine their potential
role in pain syndromes such as visceral hyperalgesia. Colonic DRG neurons were identified
by injecting Fast Blue and DiI retrograde tracers into the mouse colon. Using immuno-
fluorescence, we found that DiI-labelled neurons contained PAR2 immunoreactivity, confirming
the presence of receptors on colonic neurons. Whole-cell current-clamp recordings of acutely
dissociated neurons demonstrated that PAR2 activation with a brief application (3 min) of PAR2
agonists, SLIGRL-NH2 and trypsin, evoked sustained depolarizations (up to 60 min) which
were associated with increased input resistance and a marked reduction in rheobase (50% at
30 min). In voltage clamp, SLIGRL-NH2 markedly suppressed delayed rectifier I K currents (55%
at 10 min), but had no effect on the transient I A current or TTX-resistant Na+ currents. In
whole-cell current-clamp recordings, the sustained excitability evoked by PAR2 activation was
blocked by the PKC inhibitor, calphostin, and the ERK1/2 inhibitor PD98059. Studies of ERK1/2
phosphorylation using confocal microscopy demonstrated that SLIGRL-NH2 increased levels of
immunoreactive pERK1/2 in DRG neurons, particularly in proximity to the plasma membrane.
Thus, activation of PAR2 receptors on colonic nociceptive neurons causes sustained hyper-
excitability that is related, at least in part, to suppression of delayed rectifier I K currents. Both
PKC and ERK1/2 mediate the PAR2-induced hyperexcitability. These studies describe a novel
mechanism of sensitization of colonic nociceptive neurons that may be implicated in conditions
of visceral hyperalgesia such as irritable bowel syndrome.
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The irritable bowel syndrome (IBS) is a common disorder
affecting daily living and quality of life (Lembo et al. 2005).
Of those symptoms that characterize IBS (i.e. abdominal
pain, altered bowel pattern such as constipation and
diarrhoea, abdominal bloating and altered defecation),
abdominal pain is reported to be most troublesome and
best correlates with severity of illness (Sandler et al. 1984).
The lack of available therapies to effectively manage this
pain continues to stimulate studies of the mechanisms that
underlie this pain and to define novel therapeutic targets.
Visceral hypersensitivity (i.e. an increased sensitivity
to stimuli arising from the intestinal wall) is widely
recognized to underlie abdominal pain in IBS, at least in
a significant subset of patients (gado-Aros & Camilleri,
2005). Both central and peripheral mechanisms have
been implicated and their relative role may be dependent
on the clinical setting. In the periphery, sensitization of
nociceptive nerve endings in the wall of the colon appears
to be important. This may result from signalling from
low levels of persisting cytokines in conditions such as
post-infectious IBS (Spiller & Campbell, 2006), although
there is also growing evidence that release of mast cell
mediators may contribute to peripheral sensitization in
IBS (Barbara et al. 2004).
Of the many substances released from mast cells,
proteases such as tryptase may play a particularly
important role in signalling to neurons (Barbara et al.
2004; Spiller & Campbell, 2006). The number of
tryptase-containing mast cells is increased in intestinal
tissues of patients with IBS (Barbara et al. 2004; 2006).
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Moreover, tryptase levels in tissues, and tryptase release
from biopsies are increased in IBS patients (Barbara
et al. 2004). Proteases such as tryptase can signal to
enteric (Reed et al. 2003) and dorsal root ganglia
(DRG) (Vergnolle et al. 2001) neurons by cleaving and
activating protease-activated receptors (PARs) to induce
sustained increases in their excitability. While hyper-
excitability of enteric neurons could result in disturbances
in intestinal secretion and motility, hyperexcitability of
DRG neurons could be an important mechanism of
peripheral sensitization in conditions such as IBS (Mawe
et al. 2004; Beyak & Vanner, 2005; Lomax et al. 2006).
Although whole-animal studies have demonstrated a role
for mast cell proteases signalling to PARs in the genesis of
visceral hypersensitivity (Vergnolle et al. 2001), the precise
mechanism(s) by which this occurs remain unclear.
Certain serine proteases that are generated and released
during inflammation can signal to cells by cleaving
protease-activated receptors (PARs), a family of four
G-protein-coupled receptors. Cleavage exposes a tethered
ligand domain that binds to and activates the cleaved
receptors. Synthetic peptides that correspond to the
tethered ligand domain of PAR1, PAR2, and PAR4 directly
activate these receptors and are useful tools to probe
receptor function. Of the four cloned PARs, tryptase
selectively activates PAR2, and trypsins are also potent
activators of this receptor (Saito & Bunnett, 2005).
PAR2 is expressed by DRG and enteric neurons, and
PAR2-selective activating peptides induce hyperexcitability
of these neurons. Although the digestive tract is the
richest source of proteases that can activate PAR2, such
as tryptase and trypsins, the effect of PAR2 agonists on
hyperexcitability of colonic nociceptive DRG neurons has
not been examined. Moreover, although PAR2 agonists
are known to cause hyperexcitability of DRG neurons
(Amadesi et al. 2004), the mechanisms of this effect are
unknown. In the present study we examined the effects of
PAR2 activation with a selective agonist on the neuronal
excitability of mouse colonic DRG nociceptive neurons.
Our aims were to (1) determine if colonic DRG neurons
express immunoreactive PAR2, using retrograde tracing
and immunofluorescence; (2) examine whether activation
of PAR2 results in hyperexcitability of these neurons, and
to identify any effects upon voltage-gated potassium or
sodium currents using electrophysiological approaches;
(3) identify the kinases that mediate PAR2-induced
hyperexcitability using pharmacological approaches; and
(4) determine if activated kinases are appropriately
localized to regulate the affected ion channels, using
immunofluorescence and confocal microscopy. Small
DRG neurons were studied because these neurons express
properties associated with nociceptors (Gold et al. 1996a;
Yoshimura & de Groat, 1999; Moore et al. 2002; Beyak &
Vanner, 2005). We found that PAR2 activation evoked a
sustained hyperexcitability of these colonic neurons, and




Synthetic peptides corresponding to the tethered ligand of
rat and mouse PAR2 (PAR2-activating peptide, PAR2-AP,
SLIGRL-NH2) and the reverse peptide sequence that
does not activate PAR2 (PAR2-reverse peptide, PAR2-RP,
LRGILS-NH2, control) were from Sigma Genosys (The
Woodlands, TX, USA). All other chemicals were obtained
from Sigma, with the exception of TTX and PD98059
(Calbiochem). All agonists were applied to the bath
using a fast-flow solution-switching system (VC6; Warner
Instruments) and a three-barrel square glass (Harvard
Apparatus). In electrophysiological studies involving
PD98059, the cells were incubated with the drugs for
a minimum of 2 h before the experiment began. Both
PD98059 and calphostin C were included in the bath and
pipette solutions.
Animals
Electrophysiological studies were conducted on CD-1
mice (Charles River Laboratories, Montreal, QC, Canada)
of either sex, weighing 30–40 g. Immunohistochemical
studies were conducted on C57Bl6 mice (6–8 weeks)
from Jackson Laboratories (Bar Harbour, ME, USA)
and Sprague-Dawley rats (male, 200–250 g) from Charles
River Laboratories (Wilmington, MA, USA). The Queen’s
University Animal Care Committee and the UCSF
Institutional Animal Care and Use Committees approved
and monitored all procedures with these animals. At
the end of experiments, animals were killed using
sodium pentobarbitone (200 mg kg−1, i.p.) and bilateral
thoracotomy.
Retrograde labelling of colonic neurons
Mice or rats were anaesthetized with isoflurane (5%) or a
combination of ketamine hydrochloride (Pfizer; New York,
NY, USA) 18.75 mg ml−1 and xylazine (Bayer; Etobicoke,
ON, USA) 1.25 mg ml−1 injected i.p. (0.1 ml (10 g body
weight)−1). The descending colon was exposed by a
midline laparotomy. A 25 μl syringe (Hamilton, Reno,
Nevada, USA) with a 30–32 gauge needle was used to inject
Fast Blue (17 mg ml−1, volume = 1.0 μl per injection) or
1,1-dioctadecyl-3–3-3′3′ -tetramethylindocarbocyanine
(DiI) (5–17 mg ml−1 in DMSO) into 5–10 sites along
the colon wall (volume = 10 μl per injection site), as
previously described (Beyak et al. 2004). Excess dye was
removed using a cotton swab to prevent the dye leaking
to other tissues. The abdomen was irrigated with saline
and sutured closed. After surgery, animals were allowed
to recover on a warming blanket and were given free
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access to water and food. After recovery from anaesthesia,
animals were monitored for signs of pain, feeding, and
weight loss. Animals that displayed behaviour consistent
with ongoing pain or failure to thrive were killed.
Immunohistochemical localization of PAR2
Ten to fifteen days following DiI injection, animals were
killed using sodium pentobarbital (200 mg kg−1 i.p.). DRG
(T9–L1, T5 for control) were immersion fixed in 4%
paraformaldehyde in 100 mm PBS pH 7.4 for 4 h at 4◦C,
washed with PBS and placed in a 25% sucrose solution
overnight at 4◦C. DRG were embedded in OCT compound
(Miles, Elkhart, IN, USA) and sectioned at 25 μm. Sections
were washed in PBS containing 1–10% NGS, 1% BSA
and 0.3–0.5% Triton X-100, and incubated with primary
antibodies to PAR2 (mouse DRG, A5, 1 : 750; rat DRG,
SAM11, 1 : 250) overnight at 4◦C. Sections were washed
and incubated with goat anti-antirabbit or antimouse
IgG conjugated to FITC (1 : 200, room temperature, 2 h).
Sections were washed and mounted in Prolong (Molecular
Probes, Eugene, OR, USA). Mouse monoclonal antibodies
to PAR2 (SAM11) were from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Rabbit antibody to PAR2 (A5)
was from Dr M. Hollenberg (Calgary University). Goat
antimouse or antirabbit IgG conjugated to FITC was from
Jackson ImmunoResearch (West Grove, PA, USA).
Isolation and culture of DRG neurons for ERK
phosphorylation studies
Mice and rats were killed using sodium pentobarbital
(200 mg kg−1 i.p.). DRG from thoracic and lumbar spinal
cord were minced in cold Hank’s balance salt solution
(HBSS) (Steinhoff et al. 2000; Amadesi et al. 2004). Mouse
DRG were digested by incubating in DMEM containing
1 mg ml−1 collagenase type 1A and 0.8 mg ml−1 DNAse
type IV, for 60 min at 37◦C. This solution was removed
and neurons were incubated for 45 min at 37◦C with
DMEM containing 0.25% trypsin. Rat DRG were digested
by incubating in Dulbecco’s modified Eagle’s medium
(DMEM) containing 0.5 mg ml−1 trypsin, 1 mg ml−1
collagenase type IA and 0.1 mg ml−1 DNAse type IV (all
from Sigma, St Louis, MO, USA) for 60–90 min at 37◦C.
After digestion, soybean trypsin inhibitor (Sigma, 0.5%)
was added to neutralize trypsin. Neurons were pelleted,
suspended in DMEM containing 10% fetal bovine serum,
10% horse serum, 100 u ml−1 penicillin, 0.1 mg ml−1
streptomycin, 2 mm glutamine and 2.5 μg ml−1 DNAse
type IV, plated on glass coverslips coated with Matrigel
(BD Biosciences, Bedford, MA, USA), and cultured for
2–3 days.
ERK phosphorylation assays
Neurons in short-term culture (48–72 h) were incubated
for 18 h at 37◦C in DMEM containing 1% horse serum,
1% fetal bovine serum, 100 u ml−1 penicillin, 0.1 mg ml−1
streptomycin, 2 mm glutamine and 2.5 μg ml−1 DNAse IV.
Neurons were washed and incubated for 30 min at
37◦C in DMEM containing 0.1% BSA (protease-free).
Neurons were challenged by addition of SLIGRL-NH2
(PAR2-AP) or LRGILS-NH2 (PAR2-RP) (both 100 μm) or
PMA (1 μm) for 0–30 min. Neurons were immediately
washed in ice-cold PBS (100 mm, pH 7.4), and were
fixed in 4% paraformaldehyde in PBS for 20 min at
room temperature. Neurons were incubated for 30 min at
room temperature in PBS containing 1% NGS and 0.1%
saponin, and were incubated overnight at 4◦C with pERK
antibody (1 : 500). Neurons were washed and incubated
with goat antimouse IgG conjugated to FITC (1 : 200,
room-temperature, 1 h). Slides were washed, fixed for
20 min in paraformaldehyde, and mounted in Vectashield
with DAPI (Vector Laboratories, Burlingame, CA, USA).
Mouse monoclonal antibodies to phosphorylated ERK1/2
(pERK1/2, E4) were from Santa Cruz Biotechnology (Santa
Cruz, CA, USA).
Confocal microscopy
Specimens were observed using a Zeiss Axiovert micro-
scope, a Bio-Rad MRC1000 confocal microscope, with a
Zeiss Plan Apo ×40 (NA 1.4) objective for tissue sections
and a Zeiss Plan Apo ×100 (NA 1.3) objective for cultured
neurons. Images were collected at laser intensities of
3–30%, an iris of 2.5–3 mm and a zoom of 1–2, and
typically 5–10 optical sections were taken at intervals of
0.5–1.0 μm. Images were processed to adjust contrast and
brightness using Adobe Photoshop 7.0 (Adobe Systems,
Mountain View, CA, USA). In experiments to localize
pERK1/2 in cultured neurons, images were collected under
identical conditions (laser intensity, iris and gain) for
control and stimulated neurons.
Electrophysiological studies
Neurons were acutely dissociated as previously described
(Beyak et al. 2004). Briefly, tissue was incubated
in collagenase (Worthington; Lakewood, NJ, USA)
1 mg ml−1 and dispase (Roche; Indianapolis, IN, USA)
(4 mg ml−1) for 10 min at 37◦C, titurated with a
fire-polished Pasteur pipette, and incubated for an
additional 5 min at 37◦C. Dissociated neurons were plated
onto vitrogen-coated coverslips and stored in a humidified
incubator at 37◦C, under 95% air–5% CO2 until retrieval
(4–24 h) for electrophysiological studies. The incubating
media was obtained from a stock solution containing 10 ml
fetal bovine serum, 1 ml penicillin/streptomycin, 0.028 g
glutamine, 0.6 g dextrose and 0.2 g NaHCO3, and made up
to 100 ml with DMEM (pH 7.2–7.3).
Whole-cell or perforated-patch-clamp electro-
physiological experiments were performed in current or
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voltage clamp at room temperature. Neurons adhering
to the glass coverslip were placed in an RC-26 recording
chamber (Warner Instruments; Hamden, CT, USA),
which was mounted on the stage of an inverted micro-
scope (Olympus IX70; Tokyo, Japan) fitted for both
bright-field and fluorescence microscopy. With the
use of the U-MWIG2 filter (Olympus) for Fast Blue,
labelled colonic neurons were identified by their bright
blue fluorescence. All cells were labelled with Fast Blue
except in some latter experiments where a few unlabelled
neurons were studied because of relatively lower numbers
of labelled neurons. Almost all of these latter experimental
groups had ∼50% or more labelled neurons, and no
differences were observed between labelled and unlabelled
neurons. Only small neurons (≤25 μm diameter and
≤40 pF capacitance) were studied, because these neurons
express properties associated with nociceptors (i.e.
capsaicin sensitivity, TTX-resistant action potentials)
(Gold et al. 1996a; Yoshimura & de Groat, 1999; Moore
et al. 2002; Beyak & Vanner, 2005) Recordings were
obtained using G85165T-4 patch glass capillary tubing
with flame-polished ends (Warner Instruments), pulled
with a PP-830 micropipette puller from Narishige (East
Meadow, NY, USA), and fire-polished by using an
FP-830 fire polisher (Narishige). Final pipette resistance
was between 2 and 5 M for all experiments. Signals
were amplified using an Axopatch 200B amplifier and
digitized with a Digidata 1322A A/D converter from Axon
Instruments (San Jose, CA, USA). Signals were low-pass
filtered at 5 kHz, acquired at 20 kHz, and stored on disk
using Clampex 8.2 (Axon Instruments).
Data were only analysed from recordings that exhibited
the following properties. The starting seal resistance
between the cell membrane and the electrode tip was
≥1 G. The starting series resistance was ≤20 M, and
remained stable throughout the experiment. In current
clamp, cells had a stable resting membrane potential
more negative than −45 mV for more than 5 min before
recording, and displayed overshooting action potentials
(peak ≥ +50 mV) for the duration of the experiment.
In voltage clamp, the leak current was ≤0.5 nA when
tested at a holding potential of −100 mV throughout
the experiment. All perforated-patch recordings were
obtained using amphotericin B from Sigma (St Louis, MO,
USA) as previously described (Rae et al. 1991). Briefly,
amphotericin B stock solution was made by diluting
6 mg of powder into 100 μl dimethylsulfoxide (DMSO)
(Sigma), followed by sonication and vortex-mixing.
Immediately prior to experiments, 20 μl of stock solution
were added into 5 ml of internal pipette solution. The
solution was vortexed until a uniform light-yellowish tint
developed, then covered with aluminium foil to prevent
exposure to light. The final amphotericin B concentration
was 240 μg ml−1. Due to the compound’s photosensitivity
and rate of breakdown upon exposure to light, pipette
solutions with amphotericin B were replaced every 2 h.
Pipette tips were dipped briefly into amphotericin-free
internal pipette solution, then back-filled with unfiltered
amphotericin-containing solution.
Current-clamp recordings were carried out in
perforated-patch mode using the following solutions
(mm): (pipette) 140 KCl, 10 Hepes, 5 EGTA, 4 Na2-ATP,
5 MgCl2, 2.5 CaCl2 with pH adjusted to 7.2 using KOH;
(bath), 140 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10 Hepes, and
10 d-glucose, with pH adjusted to 7.4 using NaOH.
The membrane potential was continuously monitored
using Clampex 8.2. After a stable membrane potential was
recorded for 5 min, membrane potential, rheobase, twice
rheobase, and input resistance were recorded. Cells were
then superfused with PAR2-AP or PAR2-RP (both 100 μm)
for 3 min and the parameters were again measured at
3, 10, 30 and 60 min after application of the peptide.
Rheobase was recorded using 180 ms steps in 0.01 nA
increments, which continued until an action potential
was fired and the current needed to generate the action
potential was recorded. Input resistance was recorded
using a single 180 ms hyperpolarizing step command equal
to the negative value of the cell’s rheobase, and varied
between −0.1 and −0.3 nA. The membrane response to
the PAR2 agonist trypsin (300 nm) was tested in a separate
series of experiments.
To record potassium currents, perforated patch
was first established using the current-clamp bath
solution described above. After perforation was complete,
sodium-free bath solution was perfused onto the cell to iso-
late potassium currents. The composition (mm) was: 140
NMDG, 4 KCl, 1.8 Hepes, 1 d-glucose, 1 CaCl2, 1 MgCl2,
pH adjusted to 7.4 using HCl. Pipette solution composition
was (mm): 110 K-aspartate, 30 KCl, 10 EGTA, 10 Hepes, 2
Na2-ATP, 1 MgCl2, pH adjusted to 7.2 using KOH.
To study the effect of PAR2 activation on IA and IK
currents, neurons were superfused for 3 min with PAR2-AP
or PAR2-RP (both 100 μm). IA and IK currents were
separated using voltage protocols, as previously described
(Stewart et al. 2003). Briefly, IK was isolated using 400 ms
depolarizing steps in 15 mV increments from −90 mV
to +45 mV at a holding potential of −60 mV, with the
sustained IK measured isochronally, 400 ms after the onset
of the pulse, at which time IA was largely inactivated, mini-
mizing contamination by this current. The IA was isolated
by subtracting the sustained IK from the total potassium
current recorded using 400 ms depolarizing steps in 15 mV
increments from −90 mV to +45 mV from a holding
potential of −100 mV. Peak IA was measured as the peak
of the transient component of this subtracted current.
Recordings were made at the beginning of the experiment
and at 3, 5, 10 and 15 min following the application of the
peptide.
Voltage-clamp studies of Na+ currents were carried out
in whole-cell mode. All recordings were obtained with the
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following solutions (mm): (pipette) 110 CsCl, 1 MgCl2,
11 EGTA, 10 Hepes, 10 NaCl, pH adjusted to 7.2 with
CsOH; (bath), 55 NaCl, 80 cholineCl, 2 CaCl2, 1 MgCl2,
10 Hepes, and 5 d-glucose, pH adjusted to 7.4 using NaOH.
The low extracellular sodium concentration was used to
reduce the size of the sodium currents, enabling them to be
accurately clamped. Na+ currents were recorded in voltage
clamp using 30 ms depolarizing steps in 5 mV increments
from −80 to +40 mV at a holding membrane potential of
−100 mV. TTX-resistant Na+ currents were isolated with
TTX (1 μm). The PAR2 agonist SLIGRL-NH2 (100 μm)
or LRGILS-NH2 (100 μm) was then superfused for 3 min,
and voltage protocols in the presence of TTX repeated at
3, 5, and 10 min following application of the peptide.
Conductance was determined using the relation:
G = I/(Vm − EX)
where G is the conductance, I is the measured membrane
current, V m is the command voltage, and EX is the
equilibrium potential, which was calculated to be −84 mV
for potassium and +89.82 mV for sodium in control
solutions. Normalized average conductances were plotted
against membrane potential and the resultant curve was
fitted to a Boltzmann function of the form:
G/Gmax = 1/(1 + exp[V50 − Vm/k])
where G is the conductance, Gmax is the fitted
maximal conductance, V 50 is the membrane potential for
half-activation, V m is the command potential, and k is the
slope factor.
Inactivation curves were measured using a two-pulse
protocol, as previously described (Yoshimura & de Groat,
1999; Stewart et al. 2003). IA inactivation curve studies
used a 1 s prepulse varying between −120 and 0 mV,
followed by a 400 ms test pulse of +50 mV. IK inactivation
curves were generated using a two-pulse protocol: an
8 s prepulse varying between −80 and 0 mV, followed
by a 1 s test pulse of +50 mV. TTX-R sodium current
inactivation curves were generated using a two-pulse
protocol: a 1 s prepulse between −120 and 0 mV, followed
by a 30 ms test pulse to 0 mV. Residual current amplitudes
were normalized and plotted against conditioning pulse
potential, and the continuous line in Fig. 4E is an average
of fits to a negative Boltzmann function:
I/Imax = 1/(1 + exp[V50 − Vm/k]),
where I is the current, Imax is the maximal current, V 50
is the membrane potential for half-activation, V m is the
command potential, and k is the slope factor.
Statistical analysis
Electrophysiological recordings were analysed using
Clampfit 8.2 software (Axon Instruments). Linear leak
subtraction was used for all experiments with the P/N
Clampfit protocol. Values obtained at various time points
were expressed as a difference (absolute or percentage)
from the resting membrane potential at t = 0 min. Data are
expressed as means ± s.e.m. A two-way analysis of variance
(ANOVA) with a Bonferroni post hoc test for significance
was carried out to compare the results at every time point,
and data values were deemed statistically significant if
P < 0.05. Data from Fast Blue and non-labelled cells were
also compared at every time point and were always found to
be statistically insignificant (P > 0.05). Fitting of data was
done with the least squares method using the fit function in
Prism 4.0 (Graphpad Software). Voltages of half-activation
(V 50), time constants, and slope factors were obtained
from means of the individual Boltzmann curve fits.
Results
PAR2 is expressed in colonic neurons
We have previously reported that nociceptive neurons of
rat DRG that express TRPV1, CGRP and SP also express
PAR2 (Steinhoff et al. 2000; Amadesi et al. 2004). To
determine if those DRG neurons innervating the colon
contain PAR2, we used retrograde tracing. When the tracer
DiI was injected into the distal colon of mice, labelled
DRG neurons could be detected in DRG from T9–L1 after
10–15 days (Fig. 1A). These neurons expressed immuno-
reactive PAR2 (Fig. 1B and C). Since we have previously
reported that PAR2 is expressed by nociceptive DRG
neurons in rats, and because intracolonic administration
of PAR2 activators causes hyperalgesia to distension of the
rat colon, we also determined if DRG neurons innervating
the colon express PAR2 in this species. When DiI was
injected into the distal colon of rats, labelled DRG neurons
were detected in DRG from T9–L1 after 10–15 days
(Fig. 1D). These neurons expressed immunoreactive PAR2
(Fig. 1E and F). Together, these results show that DRG
neurons that innervate the distal colon of mice and rats
express PAR2.
PAR2 activation on mouse colonic DRG neurons
evokes sustained hyperexcitability
Current-clamp recordings were obtained from 64 DRG
neurons. Only small neurons were chosen for study (cell
diameter≤25 μm and a capacitance≤40 pF) because these
small cells have been shown to have properties exhibited
by nociceptors (Beyak & Vanner, 2005). The mean resting
membrane potential was −51.6 ± 1.6 mV. The mean input
resistance was 585.29 ± 65.80 M. All action potentials
obtained displayed a shoulder on the repolarizing phase of
the action potential, characteristic of TTX-resistant action
potentials on nociceptive DRG neurons (Beyak & Vanner,
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2005). Fewer than 10% of cells displayed spontaneous
action potentials.
We have previously shown that PAR2 activation on
guinea-pig submucosal (Reed et al. 2003) and rat DRG
neurons (Amadesi et al. 2004) caused a sustained decrease
in rheobase and in rat DRGs a prolonged membrane
depolarization. To evaluate the effect of PAR2 activation
on mouse colonic DRG neurons, Fast Blue-labelled
neurons were superfused for 3 min with the PAR2-AP
(100 μm) and changes in passive and active membrane
properties were compared to baseline for 60 min. Super-
fusion of PAR2-AP (n = 5) caused a significant membrane
potential depolarization at 3 min (mean = 6.8 mV; range:
2.1–12.4 mV) in all neurons tested, which peaked by
10 min (mean = 7.8 mV; range: 2–15.2 mV) (Fig. 2). This
depolarization, although smaller, was still evident at
60 min. In contrast, superfusion with the reverse peptide
PAR2-RP (100 μm; n = 6 Fast Blue-labelled) had no effect
on membrane potential.
PAR2-AP (100 μm) also caused a decrease in rheobase
at 3 min (mean = 55.5%; range: 33.3–71.4%), which was
maximal by 60 min (mean = 73.3%; range: 56.2–100%)
(Fig. 3B). Changes in membrane potential were controlled
for by manually applying DC current to return the
membrane potential to the resting value at each time point
before retesting the rheobase. PAR2-RP had no effect on
rheobase. Changes in input resistance were monitored
Figure 1. Localization of immunoreactive PAR2 in retrogradely labelled DRG from mouse (A–C) and rat
(D–F) DRG
DiI was injected into the wall of the distal colon and PAR2 was localized in DRG (T9–L1) 10–15 days later. A
and D, DiI; B and E, immunoreactive PAR; C and F, merge. DiI-labelled neurons innervating the colon expressed
PAR2 immunoreactivity. Representative images are shown from experiments on n = 3 animals. Scale bar = 20 μm.
Arrows show labelled neuron.
with constant hyperpolarizing pulses (see trace in Fig. 2A).
PAR2 activation caused a significant increase in input
resistance at 3 min (mean = 68.3%; range: 5.44–201.94%),
which was maximal by 60 min (73.3%; range: 49.4–108%)
(Fig. 3C). Conversely, the reverse peptide had no effect
on input resistance. Most neurons fired one or two
action potentials when depolarized at 2× rheobase. These
numbers did not change following activation of PAR2
receptors (data not shown).
In a separate series of experiments, the PAR2-AP
(1–100 μm) displayed a dose-dependent effect on
membrane potential (Fig. 2C). Two out of eight
neurons did not respond to 30 μm and 100 μm
PAR2-AP. Superfusion of the PAR2 agonist trypsin
(300 nm) also evoked slow depolarizations (mean peak
amplitude = 3.8 ± 0.53 mV; n = 7).
The effects of PAR2-AP on action potential duration
and slope were also evaluated in a separate series
of experiments, using short-duration depolarizing
pulses (30 ms). Following PAR2 activation, the mean
action potential duration (n = 4) at one-half the
peak amplitude (Fig. 3) was longer at all time
points (3–15 min; n = 6) and statistically significant
at 15 min (0 min mean = 3.18 ± 0.53 versus 15 min
mean = 3.48 ± 0.50; P < 0.05, n = 6). The action potential
duration was unchanged in control neurons (n = 4)
over a similar time period (0 min mean = 2.49 ± 0.49 ms
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versus 10 min mean = 2.49 ± 0.46 ms). The rising slope
of the action potential was measured up to 10 min
following PAR2 activation (n = 5), and was not altered
(0 min mean = 133.41 ± 11.43 mV ms−1 versus 0 min
mean = 121.77 ± 17.63 mV ms−1).
Figure 2. PAR2-AP evokes sustained depolarization of mouse
colonic DRG neurons
A, representative traces showing PAR2-AP (SLIGRL; 100 μM)
superfusion for 3 min caused a sustained depolarization of mouse
DRG neurons for up to 60 min. This was associated with action
potential discharge in a few neurons (upper trace) and an increase in
input resistance (brief downward deflections evoked by constant
hyperpolarizing pulse). Parallel lines (lower trace) represent 16 min
break in recording. Each neuron was recorded for 5 min prior to
application of the PAR2-AP (not shown) to ensure a stable resting
membrane potential. B, summary of mean depolarization at each time
point following superfusion of PAR2-AP (100 μM). The reverse peptide,
which lacks biological activity at the PAR2 (PAR2-RP, LRGILS; 100 μM),
had no effect on membrane potential. n = 5 or more for each time
point. C, PAR2-AP (1–100 μM) evoked a dose-dependent
depolarization. n = 5 or more neurons at each point.
Effect of PAR2 activation on K+ and Na+ currents
Numerous studies, including our own (Stewart et al.
2003; Beyak & Vanner, 2005), have shown that intestinal
inflammation and specific inflammatory mediators causes
a significant increase in TTX-resistant Na+ currents
Figure 3. PAR2-AP-evoked sustained hyperexcitability of mouse
colonic DRG neurons
A, representative recording showing rheobase was markedly reduced
10 min (right trace) following a 3 min superfusion of PAR2-AP
(100 μM) compared to time 0 (left trace). The membrane potential was
returned to the resting value by injecting depolarizing current at each
time point before testing for changes in rheobase. Inset shows that
the action potential duration was increased following PAR2 activation.
Rheobase was determined using a series of 0.01 current steps (not
shown) and recording the current necessary to elicit an action
potential. B, summary of percentage decrease in rheobase over time
showing change was sustained up to 60 min. In contrast, the PAR2-RP
has no effect. n = 5 Fast Blue-labelled neurons at each time point.
∗P < 0.05 C, summary of mean changes in input resistance at each
time point showing sustained increase in input resistance. PAR2-RP
had no effect. n = 5 Fast Blue-labelled neurons at each time point.
∗P < 0.05.
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Figure 4. PAR2 activation suppressed IK currents
A, representative recordings of transient (IA) and sustained (IK) K+ currents before (left traces) and 10 min
following the application of PAR2-AP (100 μM) (right traces). Currents were measured in voltage clamp from a
holding membrane potential of −100 mV or −60 mV using 400 ms steps of 15 mV from −90 mV to +45 mV. IA
was measured by subtracting recordings obtained at a holding membrane potential of −60 mV from recordings
obtained at a holding membrane potential of −100 mV. IA was measured as the peak current in the subtracted
recordings. IK was measured from the trace obtained at a holding membrane potential of −60 mV at t = 400 ms.
B and C, summary of the mean current densities following PAR2 activation for IA and IK, respectively. IA peak
current density was not altered, but the IK peak current density was suppressed. Neurons were superfused for
3 min with PAR2-AP (n = 7) or PAR2-RP (n = 8) (100 μM). ∗P < 0.05. D, current–voltage relationship for delayed
rectifier IK current showing onset of the PAR2 effect at ∼−45 mV ∗P < 0.05. E, PAR2-AP did not significantly alter
IA or IK activation (G/Gmax) or inactivation kinetics (I/Imax). Activation curves for IA and IK were measured using
5 mV steps from −80 to +50 mV, and for TTX-R sodium currents from −80 to +10 mV. Normalized conductance
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Table 1. The effect of PAR2 activation on V50 and k-values
PAR2-AP PAR2-RP
Experiment V50 (mV) k V50 (mV) k
IA
Activation −22.7 ± 6.8 27.9 ± 9.2 −15.2 ± 4.4 21.8 ± 4.9
Inactivation −59.2 ± 1.5 −12.7 ± 1.3 −59.6 ± 1.7 −11.9 ± 1.4
IK
Activation −4.3 ± 5.2 19.8 ± 4.9 10.1 ± 5.4 26.6 ± 3.8
Inactivation −49.7 ± 2.8 −18.2 ± 3.6 −52.1 ± 3.4 −18.5 ± 4.0
TTX-R Nav
Activation −43.4 ± 1.2 3.8 ± 1.0 −41.5 ± 1.0 3.9 ± 0.8
Inactivation −29.9 ± 1.5 −5.7 ± 1.3 −31.3 ± 0.5 −5.3 ± 0.4
PAR2 activation did not alter voltage of half-activation/inactivation (V50) or the slope
(k) in IA, IK, or TTX-resistant Na+ currents.
(Nav1.8) and/or a suppression of transient IA, and/or
delayed rectifier IK potassium currents. We therefore
examined whether changes in these currents may underlie
the effects of PAR2 activation on neuronal excitability.
IA and IK currents. In the whole-cell voltage-clamp mode
we observed a frequent run-down in K+ membrane
currents over a 5–10 min period. Preliminary studies
using the perforated-patch-clamp mode demonstrated
that, unlike in whole-cell mode, current run-down did not
occur in perforated control neurons over the 15 min time
period studied. The transient IA current was blocked by
4-aminopyridine (1 mm; n = 3), as previously described
(Stewart et al. 2003).
Using the perforated-patch technique, superfusion
of PAR2-AP (100 μm) (n = 7, 3 Fast Blue-labelled, 4
unlabelled neurons) caused a significant decrease in
IK at 3 min (mean = 23.7%; P < 0.05) (Fig. 4). This
persisted for the duration of the recording period and was
maximal by 10 min (mean = 51.5%). No differences were
observed between Fast Blue-labelled and non-labelled
neurons. In contrast, PAR2 activation had no effect on
IA currents (Fig. 4). Similarly, superfusion of PAR2-RP
(100 μm) had no effect on IA or IK (Fig. 4). Correlation
of the current–voltage relationship (Fig. 4D) for IK
demonstrated PAR2 significantly decreased currents near
−40 mV, suggesting this effect was active in the physio-
logical range of membrane potentials.
Voltage-dependence of activation and inactivation (see
Methods) were compared, to determine if changes in
these parameters could contribute to the reduced current
density observed following PAR2 activation. There were
(G/Gmax) was plotted against test pulse voltage and fitted to a Boltzmann function. While the activation curves for
PAR2-AP and PAR2-RP do not overlap, the differences at the various voltage steps are not statistically significant.
IA inactivation curves were generated using a two-pulse protocol: a 1 s prepulse varying between −120 and 0 mV,
followed by a 400 ms test pulse of +50 mV. IK inactivation curves were generated using a two-pulse protocol: an
8 s prepulse varying between −80 and 0 mV followed by a 1 s test pulse of +50 mV.
no significant differences in the activation curves for
the IA or IK currents following superfusion of PAR2-AP
(100 μm; t = 10 min) (n = 7 for activation curves, 3 Fast
Blue-labelled cells) or reverse peptide (100 μm) (n = 8,
3 Fast Blue-labelled cells). We also found no significant
difference in IA, or IK inactivation curves (Fig. 4) between
cells superfused with PAR2-AP (100 μm) (IA and IK
n = 5, unlabelled cells) and PAR2-RP. The voltage of
half-activation and inactivation (V 50) and corresponding
slope factors (k) were determined from the mean of the
individual curve fits and are summarized in Table 1. No
significant difference was found between the PAR2-AP and
corresponding PAR2-RP values for V 50 and k.
TTX-resistant Na+ currents (Nav1.8). TTX-resistant Na+
currents were obtained using whole-cell recording
techniques. In TTX (1 μμ), superfusion of cells
with PAR2-AP (100 μm) for 3 min had no effect
on TTX-resistant Na+ currents (Fig. 5; n = 5 Fast
Blue-labelled cells). Similarly, currents were not altered by
the reverse peptide (100 μm) (n = 4, 3 Fast Blue-labelled
cells). The time course of these currents was similar
to those described for slow-inactivating Nav1.8 currents
as apposed to ultra-slow-inactivating Nav1.9 currents
(Beyak et al. 2004). Previous studies have shown
that ATP enhances TTX-resistant Na+ currents in rat
DRG neurons (Park et al. 2004). Therefore, we also
examined whether ATP alters these currents in mouse
DRG neurons. When ATP (1 μm) was superfused for
3 min, TTX-resistant Na+ currents were significantly
increased by 3 min following the drug application
(285.5%; n = 3 Fast Blue-labelled cells; Fig. 5). Further
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studies were also conducted using perforated-patch-clamp
mode to provide an additional measure that effects
of PAR2 activation were not masked in the whole-cell
mode. Using the perforated-patch technique, mean
TTX-resistant Na+ currents were not altered by
PAR2 activation (0 min mean = 2374.2 ± 148.9 pA versus
10 min 1797.1 ± 352.0 pA).
Activation curves for TTX-resistant Na+ currents were
not altered (Fig. 5) by prior application of PAR2-AP
(100 μm; n = 5, Fast Blue-labelled) compared to cells
superfused with PAR2-RP (100 μm) (n = 4, 3 Fast
Blue-labelled cells). Similarly, inactivation curves were not
altered (Fig. 5) (PAR2-AP; n = 3, all Fast Blue-labelled;
PAR2-RP; n = 4, all Fast Blue-labelled). No significant
differences were observed between V 50 and k values
obtained with PAR2-AP compared to PAR2-RP (Table 1).
The threshold for activation of these Nav1.8 currents is
more hyperpolarized than that described for other species,
as previously reported (Beyak et al. 2004).
PAR2 activation of PKC and ERK1/2
ERK1/2 and PKC antagonists block PAR2-induced
neuronal excitability. To investigate whether the
observed changes in DRG neuronal excitability were
mediated by the activation of PKC and ERK1/2-dependent
pathways, the effects of the PKC inhibitor calphostin C
(1 μm) and the ERK1/2 inhibitor PD98059 (100 μm) were
studied. Calphostin C and PD98059 were added to the
Figure 5. The effect of PAR2 activation on
DRG TTX-R sodium currents
PAR2 activation did not alter TTX-resistant
sodium currents (TTX-R) in DRG neurons. A,
representative Na+ currents elicited using
30 ms steps from −80 to +40 mV. TTX-
resistant Na+ currents were isolated with
tetrodotoxin (TTX; 1 μM) applied for 3 min.
PAR2-AP (100 μM) was superfused for 3 min
and recordings obtained at t = 3, 5 and 10 min.
PAR2-AP had no effect on TTX-R Na+ currents.
B, summary of change in peak Na+ current
evoked by application of PAR2-AP (n = 5) or
PAR2-RP (n = 4). Using the protocol in A, cells
were also superfused with ATP (1 μM; n = 3).
ATP caused a significant increase in TTX-R Na+
currents. ∗P < 0.05, two-way repeated ANOVA
followed by Bonferroni post tests. C, PAR2-AP
had no effect on TTX-R-Na+ activation and
inactivation kinetics. TTX-R Na+ current
inactivation curves were generated using a
two-pulse protocol, with a 1 s prepulse
between −120 and 0 mV, followed by a 30 ms
test pulse to 0 mV. Normalized current (I/Imax)
was plotted against prepulse voltage and fitted
to a negative Boltzmann function.
intracellular pipette solution and superfused in the
extracellular medium during electrophysiological
recordings. Neurons were also incubated in PD98059 for
3 h prior to recordings.
Neurons were superfused for 3 min with the PAR2-AP
(100 μm) or PAR2-RP (100 μm), and recordings were
made at 3 and 10 min (Fig. 6). In the presence of either
calphostin C (n = 5) or PD98059 (n = 5), superfusion of
PAR2-AP had no effect on resting membrane potential,
rheobase, or input resistance. These measurements of the
membrane properties following PAR2 activation (i.e. in the
presence of inhibitors) did not differ from those obtained
following the superfusion of the reverse peptide (100 μm)
alone (P > 0.05), implying that the effects of PAR2 proceed
down PKC and ERK1/2-mediated pathways.
To examine the selectivity of PD98059 in DRG neurons,
the PKA activator forskolin (1 μm) was studied to
determine if PKA-mediated depolarizations were altered
by the ERK1/2 inhibitor PD98059 (Fig. 6). In these
studies forskolin (1 μm) was superfused for 3 min, and
changes in membrane potential were recorded at 3 and
10 min. Forskolin depolarized these neurons (n = 3, 2
Fast Blue-labelled) at t = 3 min (mean = 6.7 mV) and
10 min (mean = 6.7 mV). In separate cells, when forskolin
was applied in the presence of PD98059 (100 μm;
n = 3, 2 Fast Blue-labelled neurons), depolarizations
were not substantively different (mean = 6.3 mV at
t = 3 min, mean = 6.3 mV at t = 10 min) compared to
those obtained with forskolin alone.
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PAR2 agonists activate ERK1/2 and induce phosphorylation
of ERK1/2 at the plasma membrane. We have previously
reported that PAR2 agonists activate ERK1/2 in trans-
fected cell lines and in enterocytes that naturally express
Figure 6. Calphostin C and PD98059 blocked PAR2-evoked DRG
neuronal hyperexcitability
A, summary of mean changes in membrane potential evoked by
PAR2-AP at 3 and 10 min either alone or in presence of PKC inhibitor
calphostin C (1 μM; applied for 3 min by superfusion and in pipette) or
the ERK1/2 inhibitor PD98059 (100 μM, applied for 3 h to cultures
prior to application of PAR2-AP and in pipette). Depolarizations evoked
by the PKA agonist forskolin (1 μM) were not inhibited by PK98059,
supporting a selective action of this antagonist. B, summary of effects
of inhibitors on rheobase. C, summary of effects on input resistance.
For experimental protocol see Figs 2 and 3. The numbers in
parentheses indicate the number of cells for every experiment. ∗, δ and
ζ indicate P < 0.05 versus the PAR2-RP; two-way repeated ANOVA
followed by Bonferroni post tests.
this receptor (Defea et al. 2000). Since ERK1/2 can
phosphorylate and inhibit Kv4.2 in the CNS and thereby
enhance neuronal excitability (Adams et al. 2000), we
determined if PAR2 agonists phosphorylate and thus
activate ERK1/2 in cultured DRG neurons. In mouse
DRG neurons, there were low levels of immunoreactive
pERK1/2 in the unstimulated state (Fig. 7). When neurons
were incubated with PMA (1 μm, 5 min), as a positive
control for ERK1/2 activation, pERK1/2 was observed in
the cytosol of neurons, with the most intense signals
in close proximity to the plasma membrane (Fig. 7B).
Incubation of neurons with PAR2-RP (100 μm, 1–15 min),
a control agonist that does not activate PAR2, had no
effect on levels of detectable pERK1/2 (Fig. 7C). However,
when neurons were incubated with PAR2-AP (100 μm,
1–15 min), pERK1/2 was detected in the cytosol of many
neurons. PAR2-AP induced the appearance of pERK1/2
within 1–5 min (not shown), and by 15 min there were
strong signals in the cytosol in close proximity to the
Figure 7. Localization of pERK1/2 in cultured DRG neurons from
mice (A–D) and rats (E and F)
A, unstimulated neurons; B, PMA, 1 μM, 5 min; C, PAR2-RP, 100 μM,
15 min; D, PAR2-AP, 100 μM, 15 min; E, unstimulated neurons; F,
PAR2-AP (100 μM, 15 min). When neurons were incubated with PMA
or PAR2-AP, pERK1/2 were detected in the cytosol in close proximity to
the plasma membrane (arrows), whereas PAR2-RP (control) had no
effect on the levels of pERK1/2. Representative images are shown from
experiments with neurons prepared from n > 3 animals. Scale
bar = 20 μm.
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plasma membrane (Fig. 7D). Since we have previously
reported that PAR2 activators cause hyperexcitability of
DRG neurons in rats, we also determined if they activate
ERK1/2 in DRG neurons from this species. There were
low levels of detectable immunoreactive pERK1/2 in
unstimulated rat DRG neurons (Fig. 7E). When neurons
were incubated with PMA (1 μm) or PAR2-AP (100 μm)
for 1–15 min, pERK1/2 was detected in the cytosol of
many neurons in close proximity to the plasma membrane
(PMA, not shown, PAR2-AP 15 min, Fig. 7F). As a control,
PAR2-RP had no effect on levels of pERK1/2 in rat DRG
neurons (not shown). Together, these results suggest
that PAR2 agonists stimulate activation of ERK1/2 in
the region of the plasma membrane, where ERK1/2 may
phosphorylate and thereby control the activity of ion
channels that regulate neuronal excitability.
Discussion
This study demonstrates that PAR2 agonists applied to
neurons from mouse DRG caused a remarkably sustained
hyperexcitability of these neurons. Several steps were taken
to further clarify the relevance of this finding. Firstly,
small neurons were targeted in these studies because they
express properties associated with nociceptors (i.e. TTX-
resistant action potentials, TRPV1 receptors, substance
P and CGCP immunoreactivity) (Gold et al. 1996a;
Yoshimura & de Groat, 1999; Moore et al. 2002; Stewart
et al. 2003; Beyak et al. 2004; Beyak & Vanner, 2005).
Secondly, electrophysiological recordings were obtained
in neurons labelled with retrograde tracers injected into
the wall of the colon, confirming that these findings were
characteristic of nociceptors innervating the colon. Finally,
we also demonstrated that labelled neurons from the
colon expressed PAR2 immunoreactivity. Together, these
findings demonstrate that activation of PAR2 on the plasma
membrane of nociceptive DRG neurons innervating the
mouse colon leads to sustained hyperexcitability.
Sustained neuronal hyperexcitability
The long-lasting changes in membrane potential and
rheobase observed in this study lasted up to 1 h after a
brief application of the PAR2 agonist. We have observed
similar sustained effects on enteric neurons (Reed et al.
2003) and other studies of unidentified rat DRG neurons
(Amadesi et al. 2004). The specificity of the PAR2 agonists
used in the current study has been carefully demonstrated
in our previous studies (Reed et al. 2003; Amadesi et al.
2004) and others (Nystedt et al. 1994; Dai et al. 2004).
Consistent with these observations, in the present study
we found that PAR2-AP had a dose-dependent effect,
which was mimicked by trypsin, whereas the reverse
peptide, which lacks biological activity at PAR2, had no
effect. This specificity has also been observed in studies
demonstrating that PAR2-AP directly activates intestinal
afferents in anaesthetized animals (Kirkup et al. 2003).
Ionic mechanism(s) underlying sustained
hyperexcitability
There is considerable evidence that voltage-gated Na+ and
K+ channels underlying action potential electrogenesis
are modulated by visceral inflammation or specific
inflammatory mediators (Gold et al. 1996a; Yoshimura
& de Groat, 1999; Gebhart et al. 2002; Beyak et al. 2004;
Dang et al. 2004; Beyak & Vanner, 2005). The most
common findings are that TTX-resistant Na+ currents
(Nav1.8) are increased and/or voltage-gated K+ currents,
namely IA and IK, are suppressed. However, the specific
channel(s) affected may be dependent on the nature of
the inflammation (Beyak & Vanner, 2005c) and/or the
inflammatory mediator.
In the current study, mouse colonic DRG neurons
exhibited transient IA and sustained delayed-rectifier IK
voltage-gated K+ currents (see Fig. 4) characteristic of
other DRG neurons (McFarlane & Cooper, 1991; Stewart
et al. 2003; Dang et al. 2004; Beyak & Vanner, 2005). The
voltage and 4-AP sensitivity (Stewart et al. 2003) of the
transient K+ currents were typical of IA currents, and
the kinetics of the IK currents match those described in
other species (Stewart et al. 2003; Dang et al. 2004). We
found that the hyperexcitability following PAR2 activation
was associated with a profound suppression of the IK
currents (>50%) but not of IA. The effect was active in
the physiological range of membrane potentials (Fig. 4)
(i.e. around the threshold for action potential electro-
genesis), and therefore may contribute to the decrease in
rheobase observed with PAR2 activation. However, models
of visceral inflammation in the ileum, stomach and bladder
(Yoshimura & de Groat, 1999; Stewart et al. 2003;Dang
et al. 2004) have also shown that IA is suppressed in
models of chronic inflammation, supporting the notion
that individual mediators may signal preferentially to
selective K+ channels. Previous studies of the biophysical
and pharmacological properties of IK currents suggest
these currents may comprise three distinct currents (Gold
et al. 1996b). The molecular determinants of the channels
underlying these IK currents are currently unknown
although studies suggest candidates of the α-subunits
include KV 2.1/2.2 and 3.1/3.2 (Song, 2002; Kim et al.
2002).
In addition to the observed changes in IK currents, our
findings also suggest that PAR2 activation affects other
K+ currents. The increases in membrane depolarization
and input resistance following PAR2 activation cannot
be accounted for by IK currents, because they were not
open at the resting membrane potential. It is probable that
these changes result from closure of background or ‘leak’
K+-selective channels. These channels may be members
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of the two, and possibly four, transmembrane segment
K+ channels (Patel & Honore, 2001), which are important
targets of neurotransmitters and paracrine agents.
An array of inflammatory mediators including
adenosine, 5-HT, ATP, PGE2 and NGF have been found
to enhance TTX-resistant Na+ currents (Nav1.8) in
nociceptive DRG neurons (Gold et al. 1996a; Cardenas
et al. 2001; Zhang et al. 2002; Park et al. 2004; Beyak
& Vanner, 2005). In models of established inflammation
in the stomach, ileum, colon, and bladder (Yoshimura
& de Groat, 1999; Gebhart et al. 2002; Stewart et al.
2003; Beyak et al. 2004) these currents were also found
to be increased in neurons innervating the inflamed
segments. Somewhat surprisingly, in our study PAR2
activation had no effect on this current. To demonstrate
we could induce current increases in our neurons, we
also tested ATP and found that this mediator enhanced
currents, as predicted by other studies (Park et al. 2004).
Recent studies have also suggested TTX-sensitive Na+
currents (Nav1.7) may also be modulated by inflammation
(Black et al. 2004). We cannot conclude that PAR2
activation does not modulate these currents because
they were not examined in our study. However, this
seems unlikely given that previous studies examining the
effects of inflammation either failed to observe an effect
on TTX-sensitive Na+ current (Yoshimura & de Groat,
1999; Gebhart et al. 2002; Beyak et al. 2004) or, in the
recent study, suggested an effect on TTX-sensitive Na+
currents (Black et al. 2004), which paralleled the effects
on TTX-resistant Na+ currents. We also did not examine
the possibility that TTX-resistant Nav1.9 currents were
modulated by PAR2 activation. However our previous
studies (Beyak et al. 2004) suggest these currents are not
frequently found in nociceptive DRG neurons innervating
the mouse colon, and furthermore other studies suggest
that measurement of pharmacological effects on these
currents can be extremely difficult (Maruyama et al. 2004).
Finally, although our findings strongly suggest that PAR2
activation does not directly modulate Nav1.8 currents,
this may occur through indirect mechanisms in the whole
animal because PAR2 stimulates PGE2 and CGRP release
from nerve terminals (Steinhoff et al. 2000; Vergnolle
et al. 2003) and these agents in turn can enhance the Na+
currents (Baker, 2005; Natura et al. 2005).
PAR2 signal transduction mechanisms of
hyperexcitability in colonic DRG neurons
The intracellular mechanism(s) that underlie the sustained
hyperexcitability evoked by PAR2 activation on DRG
neurons described in this study and others is unknown.
Our findings suggest ERK1/2 signalling may play a major
role because PAR2 activation stimulates phosphorylation
of ERK1/2 at the plasma membrane (Fig. 7) where it could
modulate ion channels, and the highly selective ERK1/2
inhibitor (PD98059) (Thomas & Huganir, 2004) blocked
the PAR2-mediated effects on neuronal excitability (Fig. 6).
We were specifically interested in examining the potential
role of ERK1/2 signalling because recent reports in the CNS
(Thomas & Huganir, 2004) suggest that ERK1/2 signals not
only to nuclear pathways regulating gene expression but
also to cytoplasmic proteins including voltage-gated K+
channels. Moreover, phosphorylation of these channels in
an ERK-dependent manner in the hippocampus underlies
some forms of sustained excitability. Several recent studies
have also demonstrated activation of ERK1/2 in peripheral
DRG neurons (Seino et al. 2006; Takahashi et al. 2006).
The signal transduction pathway by which PAR2
agonists activate ERK1/2 in neurons also remains to be
defined. However, possible mechanisms include the trans-
activation of growth factor receptors, activation of protein
kinase C, andβ-arrestin-dependent activation (Defea et al.
2000; Darmoul et al. 2004). We did observe that calphostin,
a PKC blocker, also inhibited the PAR2-induced neuronal
hyperexcitability (see Fig. 6), but further studies are
needed to examine the interaction of PKC and ERK1/2.
β-arrestin-dependent mechanisms may be of particular
importance in targeting activated EERK1/2 to the
plasma membrane, where they may phosphorylate and
regulate ion channels (Defea et al. 2000; Luttrell &
Lefkowitz, 2002). Agonists of many G-protein-coupled
receptors, including PAR2, stimulate the translocation of
β-arrestins from the cytosol to phosphorylate receptors
at the plasma membrane (Dery et al. 1999; Luttrell &
Lefkowitz, 2002). β-Arrestins act to uncouple receptors
from heterotrimeric G-proteins and thereby desensitize
G-protein signalling, couple G-protein-coupled receptors
to clathrin and AP2, and thereby mediate receptor
endocytosis. β-Arrestins are also molecular scaffolds that
recruit and organize components of the MAP kinase
pathway to activated G-protein-coupled receptors, thereby
determining the subcellular location and function of
activated ERK1/2. We have shown that agonists of PAR2
promote the assembly of a stable signalling complex in
cells that includes PAR2, β-arrestins, raf-1, MEKK and
pERK1/2 (Defea et al. 2000). This complex acts to prevent
the trafficking of activated ERK1/2 to the nucleus and
instead retain ERK1/2 within the cytosol, where it could
phosphorylate and regulate other targets, including ion
channels. Whether this mechanism occurs in neurons
and permits ERK1/2 to regulate ion channels that mediate
PAR2-induced hyperexcitability, such as those underlying
IK currents, remains to be determined.
Implications of PAR2-evoked sustained
hyperexcitability of nociceptive DRG neurons
in the colon
There is growing evidence that the release of proteases
from mast cells plays an important role in the genesis of
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visceral hyperalgesia in functional bowel disorders such
as IBS (Barbara et al. 2004; Spiller & Campbell, 2006;
Barbara et al. 2006). Studies have demonstrated that
intestinal mast cell numbers are increased, at least in
subsets of patients, and that there is evidence of increased
degranulation and tissue content of mast cell tryptase.
Moreover, preliminary studies have shown that tryptase
in the supernatant of colonic biopsies from IBS patients
can stimulate calcium signals in DRG neurons (Cenac
et al. 2005), suggesting activation of these neurons. The
proximity of mast cells to nerve terminals in the intestine
has also been correlated with the severity of abdominal
pain (Barbara et al. 2004). Numerous in vitro and in
vivo animal studies have also shown that proteases, such
as tryptase, released from degranulating mast cells have
similar actions to those induced by the PAR2 agonists
used in this study. When taken together, the findings of
the current study combined with these previous studies
suggest it is possible that the sustained excitability of
nociceptive DRG neurons following PAR2 activation could
be important in the genesis of abdominal pain in patients
with IBS, and that repeated mast cell degranulation may
lead to ongoing ‘re-priming’ of these neurons.
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